Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Egyesült Államok
133 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Where
- Ann Arbor, Duarte, Houston, La Jolla, Nashville, New York, Omaha
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07195916 · EU 2025-523130-11-00 - 1. fázisTaking peopleLymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma
- Where
- Columbus
- Életkor
- 18 év and over
- People
- 18
- Run by
- Nathan Denlinger
See details and how to joinNCT07676877 - 2. fázisTaking peopleLoncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 36
- Run by
- City of Hope Medical Center
See details and how to joinNCT05672251 - 2. fázisTaking peopleEmapalumab Prevention of CAR-T Cell Associated Toxicities
- Where
- Boston
- Életkor
- 18 év and over
- People
- 28
- Run by
- Marcela V. Maus, M.D.,Ph.D.
See details and how to joinNCT06550141 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Augusta, Baton Rouge, Bethesda, Birmingham, Boston, Buffalo, Chattanooga, Detroit, Fort Collins, Houston, Iowa City, Jacksonville, La Jolla, Las Vegas, Louisville, Miami, Nashville, Newnan, New York, Palo Alto, Phoenix, Richmond, Rochester, Santa Monica, Scottsdale, Seattle, Tampa, Tucson, Zion
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - 1. fázisTaking peopleConstitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
- Where
- Houston
- Életkor
- 12 év to 75 év
- People
- 90
- Run by
- Baylor College of Medicine
See details and how to joinNCT06176690 - 2. fázisTaking peopleNemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
- Where
- Buffalo
- Életkor
- 18 év and over
- People
- 32
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT06863402 - 2. fázisTaking peopleIntrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
- Where
- Nashville
- Életkor
- 18 év and over
- People
- 59
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT07763210 - 2. fázisNot yet taking people in Egyesült ÁllamokEpcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma
- Where
- San Francisco
- Életkor
- 18 év and over
- People
- 20
- Run by
- Carrie Ho, MD
See details and how to joinNCT07588698 - 1. fázisTaking peopleLoncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)
- Where
- San Antonio
- Életkor
- 18 év and over
- People
- 10
- Run by
- The University of Texas Health Science Center at San Antonio
See details and how to joinNCT06977711 - 2. fázisTaking peopleAscorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
- Where
- Eau Claire, La Crosse, Mankato, Rochester
- Életkor
- 18 év and over
- People
- 80
- Run by
- Mayo Clinic
See details and how to joinNCT03418038 - 2. fázisTaking peoplePhase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
- Where
- Houston
- Életkor
- 18 év and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06045247 - 1. fázisTaking peopleEpcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders
- Where
- Columbus, St Louis
- Életkor
- 18 év and over
- People
- 26
- Run by
- Timothy Voorhees
See details and how to joinNCT06672705 - No phaseTaking peopleVaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
- Where
- Portland
- Életkor
- 18 év and over
- People
- 45
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT06784167 - 2. fázisTaking peopleItacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
- Where
- Tampa
- Életkor
- 18 év and over
- People
- 27
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT05757219 - 1. fázisTaking peopleZanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 23
- Run by
- City of Hope Medical Center
See details and how to joinNCT06735664 - 1. fázisCsak meghívásosCD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
- Where
- Baltimore
- Életkor
- 18 év and over
- People
- 15
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT07168486 - 1. fázisTaking peopleRituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
- Where
- Cleveland
- Életkor
- 18 év and over
- People
- 15
- Run by
- Paolo Caimi, MD
See details and how to joinNCT07225439 - 1. fázisTaking peopleA Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)
- Where
- Lexington
- Életkor
- 18 év and over
- People
- 30
- Run by
- Pierluigi Porcu
See details and how to joinNCT06789159 - 2. fázisNot yet taking people in Egyesült ÁllamokTPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma
- Where
- Providence
- Életkor
- 18 év and over
- People
- 30
- Run by
- Brown University
See details and how to joinNCT07502872 - 2. fázisTaking peopleCNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
- Where
- St Louis
- Életkor
- 18 év to 75 év
- People
- 36
- Run by
- Washington University School of Medicine
See details and how to joinNCT06687772 - 2. fázisTaking peopleOdronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 27
- Run by
- University of Washington
See details and how to joinNCT06784726 - 2. fázisTaking peopleEpcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Where
- Duarte, Newnan, Zion
- Életkor
- 18 év and over
- People
- 43
- Run by
- City of Hope Medical Center
See details and how to joinNCT07365306 - 1. fázisTaking peoplePilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
- Where
- Salt Lake City
- Életkor
- 18 év and over
- People
- 10
- Run by
- University of Utah
See details and how to joinNCT06227026 - 1. fázisTaking peoplePomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 25
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05389423